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Transcriptome-Wide Analysis of Messenger RNA Decay in
Normal and Osteoarthritic Human Articular Chondrocytes
Simon R. Tew, Benjamin T. McDermott, Rory B. Fentem,
Mandy J. Peffers, and Peter D. Clegg
Objective. Messenger RNA (mRNA) decay rates
control not only gene expression levels, but also respon-
siveness to altered transcriptional input. We undertook
this study to examine transcriptome-wide posttranscrip-
tional regulation in both normal and osteoarthritic
(OA) human articular chondrocytes.
Methods. Human articular chondrocytes were iso-
lated from normal or OA tissue. Equine articular chon-
drocytes were isolated from young or old horses at a
commercial abattoir. RNA decay was measured across
the transcriptome in human cells by microarray analy-
sis following an actinomycin D chase. Messenger RNA
levels in samples were confirmed using quantitative
reverse transcription–polymerase chain reaction.
Results. Examination of total mRNA expression
levels demonstrated significant differences in the ex-
pression of transcripts between normal and OA chon-
drocytes. Interestingly, almost no difference was ob-
served in total mRNA expression between chondrocytes
from intact OA cartilage and those from fibrillated OA
cartilage. Decay analysis revealed a set of rapidly turned
over transcripts associated with transcriptional control
and programmed cell death that were common to all
chondrocytes and contained binding sites for abundant
cartilage microRNAs. Many transcripts exhibited al-
tered mRNA half-lives in human OA chondrocytes com-
pared to normal cells. Specific transcripts whose decay
rates were altered were generally less stable in these
pathologic cells. Examination of selected genes in chon-
drocytes from young and old healthy horses did not
identify any change in mRNA turnover.
Conclusion. This is the first investigation into the
“posttranscriptome” of the chondrocyte. It identifies a
set of short-lived chondrocyte mRNAs likely to be highly
responsive to altered transcriptional input as well as
mRNAs whose decay rates are affected in OA chondro-
cytes.
Regulation of the rate of messenger RNA
(mRNA) decay performs a role in the control of steady-
state gene expression levels and the kinetics of gene
regulation (1). Impaired mRNA decay can lead to
accumulation of transcript with a consequent effect on
levels of translated protein (2). The rate of mRNA
turnover will also influence the speed at which relative
changes in mRNA expression and protein translation
occur in response to an alteration in transcriptional
input (3). Short-lived mRNAs will be induced and
turned off more rapidly than will more stable transcripts
when transcription increases (4). The processes that
regulate the rate of mRNA decay are complex and
involve the interaction of regulatory sequences within
the mRNAs themselves with proteins and noncoding
RNAs such as microRNAs (miRNAs). There is great
scope for such regulation to be further modulated, as the
finite availability of these regulators is affected by
changes in the network of protein-coding mRNAs and
nontranslated pseudogene mRNAs (5,6).
A number of studies have examined transcriptome-
wide control of gene expression in chondrocytes from
healthy and arthritic cartilage and in chondrocytes ex-
posed to various physiologically relevant conditions (7–
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14). These valuable studies continue to inform us about
the mechanisms controlling chondrocyte gene expres-
sion and the cellular processes that are underpinned by
these changes. By their nature, these current studies
examine a snapshot of the levels of genes present in
cells, and we are unable to infer from them how mRNA
turnover is affected.
Currently, examination of chondrocyte mRNA
turnover has been targeted to the regulation of specific
genes. Chondrocytic cells have been shown to regulate
genes such as inducible nitric oxide synthase and bone
morphogenetic protein 2 posttranscriptionally (15,16).
Our own work has shown that posttranscriptional con-
trol of the transcription factor SOX9 can be regulated
through stress signaling pathways (17,18). These ongo-
ing studies have also shown that hyperosmotic stress is
able to induce changes in the rate of turnover of a
number of other genes’ mRNA, indicating that chondro-
cytes, like many other cells, use widespread regulation of
mRNA turnover as a regulatory mechanism (19). Fur-
ther indirect evidence of active posttranscriptional gene
control in chondrocytes comes from studies of miRNA
expression in chondrocytes. These small noncoding
RNAs are able to control mRNA decay and protein
translation by binding to seed sequences within target
mRNAs (20). It is now clear that these molecules are
critical for proper chondrocyte function (21) and are
involved in diverse cellular processes including cell
signaling (22,23), mechanical forces (24), and tissue
pathology (22,25).
Analysis of mRNA decay using transcriptomic
approaches has been applied to a number of cell types,
and advances have been made in understanding how
mRNA kinetics are affected by cytokine signaling and
during cellular processes such as stem cell differentiation
(26–28). In this study, we examined the transcriptome-
wide rates of mRNA decay in human chondrocytes
obtained from both osteoarthritic (OA) and normal
tissue. This allowed us to examine for the first time the
patterns of mRNA turnover in these cells and to begin to
examine how this process is affected by pathology.
MATERIALS AND METHODS
Tissue collection and chondrocyte culture. Osteochon-
dral tissue was taken from femoral condyles obtained from the
knee joints of patients undergoing either limb resections as a
treatment for osteosarcoma (Royal National Orthopaedic
Hospital, Stanmore, Middlesex, UK) or total knee arthroplasty
as a result of OA (Clatterbridge Hospital, Wirral, UK). Equine
cartilage was obtained from the metacarpophalangeal joints of
horses at a commercial abattoir. The age of the animals was
determined from their legal documentation. Tissue was ob-
tained with full ethical review board approval at each center.
Cartilage was cut from the underlying subchondral bone,
diced finely, and then digested by shaking overnight in 0.08%
type II collagenase (Worthington) at 37°C. Isolated chondro-
cytes were plated at 100,000 cells/cm2 in 25-cm2 tissue culture
flasks. The basal medium used throughout this study was
Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal bovine serum, 100 units/ml penicillin, 100 units/ml
streptomycin, and 5 g/ml amphotericin B (all medium con-
stituents from Life Technologies).
Grading of tissue pathology. From each tissue sample
an osteochondral fragment grossly representative of the artic-
ular surface used for cartilage harvest was fixed in 4% forma-
lin, dehydrated, decalcified, and processed into paraffin wax
blocks. Sections (5 m) were stained with hematoxylin and
eosin or with Safranin O and were then graded by 2 blinded
observers (BTM, PDC) using a modified Mankin grading
system (29). Samples were categorized as normal if they were
obtained from non-OA joints and had a score of 10, as
having intact OA if they were from an OA joint and had a score
of 10, and as having fibrillated OA if they were from an OA
joint and had a score of 10 (Table 1).
Screening of chondrocyte RNA decay using microar-
rays. Freshly isolated chondrocytes were allowed to adhere for
16 hours, and then their media were supplemented with 1 M
actinomycin D (Sigma) for 0, 1, 3, or 5 hours. At each time
point, the cell layer was extracted using TRIzol, and total RNA
was purified using chloroform-based phase separation and sub-
sequent precipitation with isopropanol. RNA pellets were
dissolved in RNase-free H2O and stored at 80°C until re-
quired. Total RNA from the 0-, 1-, 3-, and 5-hour actinomycin
Table 1. Sample information and results of histologic grading
Category,
age/sex*
Average histologic
score
Sample
reference
Intact normal
18/M 3 N_M18†‡
15/M 0 N_M15†‡
14/M 1 N_M14‡
24/F 1 N_F24‡
21/M 3 N_M21†‡
37/F 2 N_F37†
16/F 1 N_F16†‡
Intact OA
63/M 6 I_M63†‡
80/M 8 I_M80†‡
68/F 5 I_F68†‡
78/F 9 I_F78†‡
72/F 4 I_F72‡
66/M 4 I_M66‡
Fibrillated OA
73/M 15 F_M73†
61/M 12 F_M61†
74/M 21 F_M74†
60/M 17 F_M60†
* OA  osteoarthritis.
† Used in microarray analysis.
‡ Used in real-time reverse transcription–polymerase chain reaction
analysis.
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D time points from 4 samples from each group were used to
probe Illumina HT-12 BeadChip arrays at The Genome Cen-
tre core facility at Queen Mary University of London. RNA
integrity was confirmed using an Agilent bioanalyzer, and
RNA was then labeled with Cy3 using an Ambion TotalPrep
kit before being hybridized to arrays using an Illumina Bead-
Station 500G. Non-normalized data were exported from Illu-
mina BeadStudio software and used for subsequent analysis.
Data analysis of RNA decay sample sets. Non-
normalized expression data were normalized using R 3.0.2
for Mac OS X (http://cran.r-project.org/bin/macosx/) using
a BeadArray package. For analysis of total mRNA levels,
samples obtained from each donor at time 0 were quantile-
normalized together before further data analysis. This data set
is referred to as “total.” For mRNA decay measurements,
probes that did not show significant hybridization above back-
ground at time 0 were excluded, as measurement of further
decay of mRNA would not be possible. This was determined
using the P value assigned to each hybridization. From the
remaining data, the 4 sample points of each donor’s RNA
decay curve (0, 1, 3, and 5 hours) were taken and quantile-
normalized to each other, independently of the other donors’
sample points, to ensure that overall variations of gene ex-
pression between samples did not influence the rates of
decay intrinsic to each sample (the “decay” data set). Data
were submitted to ArrayExpress (http://www.ebi.ac.uk/array
express/) for curation under accession no. E-MTAB-2723.
The “total” data were imported into the online Na-
tional Institute on Aging Array Analysis tool (http://
lgsun.grc.nia.nih.gov/ANOVA/index.html), where they were
stratified by disease state (normal, intact OA, and fibrillated
OA) and subjected to one-way analysis of variance. Significant
differences in gene expression for the “total” data set were
determined, and a 2-fold change with a P value less than 0.05
was considered significant.
The “decay” data set was analyzed in R. The slope of
the decay curves was calculated using the following equation:
slope 
4Y  XY
4X2 X2
where Y is the natural logarithm of the expression level and X
is the time of incubation with actinomycin D in hours. Each
slope value was then converted into an mRNA half-life using
the following equation:
mRNA half-life hours 
In2
slope
Longer half-life values were capped at 24 hours, and
the data were filtered to include only genes whose half-life was
a positive value in all samples. Mean values of mRNA half-
lives in normal, intact OA, and fibrillated OA samples were
calculated for each gene. Data for intact OA and fibrillated
OA samples were also pooled to create a mean OA half-life.
Ratios of half-lives from cells from different tissues were
calculated, and those with 	2-fold change were subjected to a
2-sample t-test. P values were adjusted to false discovery rates
(FDRs), and those with values of less than 0.05 were then
further screened by manual inspection of the raw data.
Gene ontology analysis. Analysis of the rapidly turned
over and differentially regulated mRNAs was performed using
both the Panther Classification System web tool (www.pant-
herdb.org) and DAVID functional annotation clustering (30).
Predicted miRNA targets of rapidly turned over chondrocyte
mRNAs were identified using the Geneset2miRNA function
within the www.BioProfiling.de web portal (31).
MicroRNA microarray analysis. Cartilage was dis-
sected from the femoral surface of osteochondral tissue ob-
tained following total knee arthroplasty. Tissue from 2 female
donors (ages 83 and 88 years) was cut into 
5-mm2 pieces and
cultured in serum-free DMEM (adjusted to 380 mOsm/liter by
adding NaCl) for 24 hours. Tissue was then snap-frozen and
powdered using a Braun Mikro-Dismembrator. RNA was
isolated from these samples and used, then partially purified
using TRIzol/chloroform before full purification using RNeasy
Spin columns (Qiagen). Total RNA (1 g) was sent to The
Genome Centre and used to probe an Illumina Universal 12 v2
1536 BeadArray as previously described (19). Data from
isolated chondrocytes from this earlier study were also reex-
amined.
Real-time reverse transcription–polymerase chain re-
action (RT-PCR) analysis. Total RNA was reverse-transcribed
using Moloney murine leukemia virus reverse transcriptase,
primed using random primers (Promega). Real-time RT-PCR
was performed on an ABI 7300 system using MESA Blue
SYBR Green reagent (Eurogentec). Expression levels were
calculated by the 2–Ct method (32). RPS13 was used as a
reference expression gene due to its low variation in our
microarray data set and its separate validation as being low in
variance across a substantial number of other studies (33).
Primer sequences are available on request from the corre-
sponding author.
RESULTS
Femoral cartilage was obtained from 7 non-OA
and 10 OA human knee joints. Table 1 shows the results
of histologic grading of the tissue. The 7 non-OA tissue
samples all had low scores when assessed histologically
by the modified Mankin grading. The OA samples were
split into 2 groups according to disease severity, as
described in Materials and Methods: 6 intact samples
with scores 10 and 4 fibrillated samples with scores
10.
Total RNA from each of the actinomycin D time
points, taken from 5 normal samples and 4 samples from
each OA group (indicated in Table 1), was used to probe
Illumina HT-12 microarrays. We first decided to exam-
ine the overall mRNA levels in each group, which was
possible by simply examining the time 0 point of the
decay curve for each sample. Our analysis was able to
show that there were a number of significantly differen-
tially regulated genes detectable between normal sam-
ples, intact OA samples, and fibrillated OA samples
(Figure 1A). Gene ontology analysis using Panther
(Figure 1B) showed enrichment of genes associated
with the extracellular compartment, particularly the
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extracellular matrix (ECM), and genes involved in bio-
logic processes such as binding, transcriptional regula-
tion, and catalysis. In many cases, the genes identified
had previously been associated with cartilage and OA
(Figure 1C) (see Supplemental Table 1, available on
the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art.38849/abstract).
This gave us confidence that our cells, despite a short
period of in vitro culture, retained intrinsic disease-
dependent differences. The genes differentially regu-
lated by OA were often similar regardless of whether the
chondrocytes were from fibrillated or intact cartilage.
Interestingly, when we compared overall mRNA expres-
sion levels between intact OA samples and fibrillated
OA samples, we observed no statistically significant
difference in expression (Figure 1A).
We next examined mRNA half-life in articular
chondrocytes. Figure 2 shows the frequency of mRNA
half-lives in each sample group. The data showed that
the majority of mRNAs in chondrocytes were extremely
Figure 1. A, Scatterplots demonstrating the relationships between log2 gene expression levels between normal chondrocytes, intact osteoarthritic
(OA) chondrocytes, and fibrillated OA chondrocytes (green and red dots represent genes that exhibit change between groups with P  0.01). B, Pie
charts representing the occurrence of major ontological annotations associated with genes significantly up-regulated and down-regulated in OA
chondrocytes, either in location (top) or in process (bottom) categories of the Panther Classification System. Exploded regions on charts emphasize
the number of extracellular-associated genes differentially regulated. C, Heatmap representing expression levels of the top 25 up-regulated and the
top 25 down-regulated genes in OA chondrocytes. Both the gene and sample lists were subjected to hierarchical clustering. Color key indicates the
normalized log2 hybridization values. Average histologic scores of samples at the bottom are shown in Table 1. ECM  extracellular matrix.
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stable. However, a substantial number of mRNAs in
each sample set exhibited rapid turnover. We observed
that the number of short-lived transcripts was higher in
chondrocytes from OA tissue than in chondrocytes from
normal tissue. This was the case when samples were
stratified by intact OA or fibrillated OA and when all
OA samples were combined together (total OA). We
next examined transcripts that had a half-life of 6
hours across all samples, to identify mRNAs that were
turned over quickly by chondrocytes regardless of pa-
thology. We identified 213 genes that consistently exhib-
ited an mRNA half-life of 6 hours (see Supplemental
Table 2, available on the Arthritis & Rheumatology web
site at http://onlinelibrary.wiley.com/doi/10.1002/
art.38849/abstract), representing 0.6% of genes whose
mRNA half-life was calculated. Using DAVID to per-
form functional annotation clustering, we found that
many of these short-lived transcripts encoded genes
localized to the nucleus and responsible for transcription
(functional annotation score 8.5), genes involved in
programmed cell death (functional annotation score
5.65), and genes that regulate embryonic development
(functional annotation score 3.27).
As mRNA decay is determined in part through
the actions of miRNAs, we were interested to know
whether the rapidly turned over mRNAs were enriched
for targets of particular miRNA molecules. Using
the Geneset2miRNA function within the www.Bio
Profiling.de web portal, we found that the short-lived
mRNAs were enriched for predicted targets of the
miRNAs miR-410, miR-323.3p, miR-200b, miR-200c,
and miR-429 (see Supplemental Table 2, available on
the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art.38849/abstract).
We took these miRNA predictions and compared them
with microarray-based miRNA expression measure-
ments that we previously conducted on isolated human
chondrocytes and explanted human OA cartilage. We
found that of the 1,145 miRNA molecules examined by
the microarray, 10% hybridized to the array at suffi-
cient levels to provide a signal of 	10,000 light units.
The miRNA miR-323.3p was among these highly ex-
pressed miRNAs. Furthermore, miR-410, miR-200b,
and miR-200c were in the top 50% of miRNAs ex-
pressed in the chondrocytes and cartilage explants.
We next directly compared the mRNA half-lives
in chondrocytes in normal and OA cartilage. We focused
on transcripts whose half-life changed by a factor of 2.
We used t-tests and subsequent FDR correction to
determine the number of mRNAs whose half-life was
significantly altered in the groups examined. We found
that 51 mRNAs were identified when comparing normal
and intact OA samples and 112 when comparing normal
and fibrillated OA samples but none when comparing
intact OA and fibrillated OA samples. Because there
was no significant difference between intact OA and
fibrillated OA samples, we chose to pool these data sets
to maximize the power of the comparison to the normal
samples. This allowed us to identify 395 mRNAs whose
half-life was significantly altered in OA chondrocytes
compared to normal chondrocytes (see Supplemental
Table 3, available on the Arthritis & Rheumatology web
site at http://onlinelibrary.wiley.com/doi/10.1002/
art.38849/abstract).
Consistent with the distributions shown in Figure
3, the majority of significantly affected mRNAs became
less stable in OA chondrocytes. Only 8 mRNAs were
more stable, representing just 2% of those identified.
We examined the relationship between the normal:OA
ratio of mRNA half-life and steady-state mRNA expres-
sion, and we found that mRNAs whose average half-life
was reduced in OA chondrocytes were generally ex-
pressed at higher levels (Figure 3A). We performed
gene ontology analysis of the genes differentially regu-
Figure 2. Profile of mRNA half-life in normal and osteoarthritic
(OA) chondrocytes and in OA chondrocytes stratified into those
isolated from intact OA and fibrillated OA tissue. The analysis caps
longer half-lives at 24 hours, which accounts for the high peak at the
far right in each panel (which extends beyond the limit of the y-axis in
each case). Inserts show the same data on zoomed y-axis.
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lated between these 2 groups using Panther. Compared
to the list of genes whose steady state was altered by OA
(Figure 1B), there was a lesser enrichment of genes
associated with extracellular space and ECM location
(Figure 3B), although the biologic properties were sim-
ilarly varied. Further analysis of this gene list using
DAVID indicated that mRNAs that were differentially
regulated between each normal and OA sample were
mainly associated with 4 annotation clusters: genes
associated with transcriptional regulatory properties
(functional annotation score 5.74), genes associated with
the nuclear lumen (functional annotation score 3.29),
genes that encode proteins containing a zinc finger
domain (functional annotation score 3.22), and genes
associated with regulation of programmed cell death
(functional annotation score 1.9).
Quantitative RT-PCR confirmation of mRNA de-
cay rates of differentially regulated genes of interest
confirmed the microarray findings (Figure 3C). The
aggrecanases ADAMTS1, ADAMTS5, and ADAMTS9,
the hyaluronic acid synthase HAS2, the heparan sulfate
sulfotransferase HS3ST3A1, and the NF-B complex com-
ponent RELA were examined by real-time RT-PCR.
We also analyzed 3 genes that had demonstrated 	2-
fold change in half-life but that had FDR values of
	0.05. JAK2 was chosen as it is a critical component of
Figure 3. Effect of osteoarthritis (OA) on mRNA decay. A, Scatterplot relating the observed fold change in total mRNA levels between normal and
OA cells to the fold change in mRNA half-life. The vertical line represents a normal:OA total mRNA ratio of 1:1, such that all points to the left
of the line represent genes with increased expression in OA. The horizontal line represents a 2-fold change in the normal:OA mRNA half-life ratio,
such that genes that are above this line are less stable in OA cells. B, Pie charts representing the occurrence of major ontological annotations
associated with genes significantly up-regulated and down-regulated in OA chondrocytes, either in location (top) or in process (bottom) categories
of the Panther Classification System. Exploded regions on charts emphasize the number of extracellular-associated genes differentially regulated.
C, Real-time reverse transcription–polymerase chain reaction analysis of mRNA decay, confirming alterations between normal and intact OA
chondrocytes in mRNA decay of selected genes. Values are mean SEM fold change in mRNA levels compared to 0 hours of the decay curve (data
from 5 normal donors and 5 OA donors; see Table 1). Data are presented for 6 genes in which the false discovery rate (FDR) was 0.05 in
microarray analysis and for 3 genes in which the average half-life was altered but the FDR was 	0.05. ECM  extracellular matrix.
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the JAK/STAT cytokine signaling pathway. SOX9 and
SASH1 were chosen because we have previously shown
their altered posttranscriptional regulation in chondro-
cytes. JAK2 (FDR 0.07) and SOX9 (FDR 0.51) did not
exhibit a change in half-life; however, the quantitative
RT-PCR data suggested that SASH1 (FDR 0.12) was
differentially regulated.
Due to the different ages of our normal human
donors and our human donors with OA, we wished to
examine how age affected the mRNA half-life of genes
that we had identified in the study. To do this, we turned
to an equine chondrocyte system, isolating the cells from
animals whose age could be accurately identified at the
time of death. We used the actinomycin D chase ap-
proach used with the human samples to create RNA
decay curves, and from these we calculated RNA half-
lives (Figure 4). We measured turnover of HS3ST3A1,
ADAMTS5, ADAMTS9, RELA, and SASH1, all of
which had differed in the quantitative RT-PCR analysis
of normal and OA human samples. We also measured
JAK2, which we had confirmed not to be differentially
regulated in the human experiments. Samples were
collected from horses ranging in age from 3 years
(equivalent to a human age of 
18 years) to 20 years
(equivalent to a human age of 
60 years) (34). We
observed 1 outlying donor (age 17 years) that consis-
tently exhibited higher half-lives for each RNA exam-
ined. Otherwise, we found no significant relationship
between age and mRNA half-life for any of the genes
examined.
DISCUSSION
This study is the first to look in detail at the
“posttranscriptome” of the human articular chondro-
cyte. Our findings show that chondrocytes, regardless of
pathology, exhibit extensive control over the turnover of
a selection of expressed transcripts. Furthermore, we
present evidence that OA leads to altered posttranscrip-
tional regulation of a number of genes. Previous studies
of chondrocyte gene expression have captured a snap-
shot of gene expression under the specifically examined
conditions. Our results begin to cast some light onto an
additional dimension of gene expression within chondro-
cytes, due to the relationship between mRNA half-life
and gene expression kinetics. We can begin to infer that
genes whose mRNA is turned over rapidly are likely to
be more responsive to transcriptional input than genes
with pools of stable mRNA. This may have profound
implications for our understanding of how chondrocytes
regulate genes in response to changes in their environ-
ment.
Although our aim in this study was to examine
RNA decay, we were able to use our data to first
determine how OA affects steady-state mRNA levels,
using the zero time point of our decay curves. There
were major changes in genes associated with enzymatic
activity and the ECM. Particular examples of these
OA-related genes included genes encoding proteinases
such as ADAMTS1, ADAMTS5, and HTRA1 (35–37).
We also identified ECM macromolecules such as
COL1A1, HAPLN1, and CILP and soluble regulatory
molecules such as IL6, WNT5A, IGFBP4, APOD, and
DKK3, which have previously been implicated in OA
progression (38–43). This demonstrated that a different
transcriptional profile, consistent with OA, was main-
tained following isolation of the cells from their ECM.
Interestingly, we found that the transcriptomes
of chondrocytes from late-stage OA joints are remark-
ably similar, regardless of whether tissue was harvested
from relatively intact or severely degenerated regions of
the articular surface. This similarity between OA chon-
drocytes in different locations has been found previously
by examining the transcriptional level of a number of
candidate genes (44). It has also been shown that intact
and degenerated OA cartilage are comparable in their
stem cell content (45). However, other work has shown
that gene expression changes can be found in cartilage at
different stages of degeneration (13,14). In our experi-
ments, it is possible that any difference in total mRNA
expression that exists in OA cells from more or less
severely affected tissue is lost during the 24-hour culture
Figure 4. Effect of age on mRNA decay of candidate genes in equine
articular chondrocytes. Plots show mRNA half-life measured in hours
from freshly isolated cells, plotted against the age in years of the donor
animal. Data are from 7 animals ranging in age from 3 years to 20
years. Symbols represent individual samples.
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period but that changes between normal and OA cells
persist.
Our preparation of a data set describing mRNA
decay in chondrocytes has not previously been at-
tempted. In general, in each cell type examined, the
mRNAs were mostly very stable with their calculated
half-life cut off by the analysis at 24 hours. Nevertheless,
there were a number of rapidly turned over mRNAs in
chondrocytes, and we were interested to find that there
appeared to be an increase in the number of these
rapidly turned over mRNAs in OA chondrocytes (Figure
2). Although this is a small change, it is consistent with
findings in embryonic stem cells, which when allowed to
differentiate, display relatively modest changes in mRNA
decay rate profile (27). By examining a core set of
mRNAs that are turned over rapidly (half-life6 hours)
in chondrocytes regardless of pathologic origin, we
identified a group of uniformly short-lived transcripts.
The gene ontologies associated with these short-lived
mRNAs provides us with an increased appreciation of
the processes that rely on rapid mRNA turnover. Given
that we know that mRNA turnover rates will affect gene
responsiveness, we can infer that it is important that the
regulation of these processes is quick and flexible in
chondrocytes. The primary groups of genes identified
are those involved in transcriptional regulation as well as
those localized to the nucleus. Furthermore, the ontology
analysis suggests that quick mRNA turnover is associated
with genes involved in the regulation of programmed
cell death, which itself can be a rapid process in chon-
drocytes (46).
The rapid turnover of a large subset of mRNAs in
chondrocytes will be controlled by regulatory factors
with specificity for these transcripts. Numerous studies
have already demonstrated a critical role of miRNAs in
the shaping of gene expression posttranscriptionally, and
key cartilage-related miRNAs continue to be discovered
(47). The data presented here illustrate the conse-
quences of this regulation in chondrocytes in terms of
RNA turnover. This has allowed us to predict the types
of miRNA that strongly influence the turnover of RNA
in chondrocytes. We have done this by using bioinfor-
matics tools to identify miRNAs whose seed sequences
were enriched in our list of commonly unstable mRNAs.
However, these lists contain many RNAs that do not
contain these seed sequences, which suggests that other
important factors exist, for instance, the influence of
multiple lower affinity miRNAs or RNA binding pro-
teins.
Despite the very similar profiles of mRNA half-
lives in all the chondrocyte populations examined, we
were excited to identify a number of transcripts whose
decay rates were altered specifically in OA chondro-
cytes. These transcripts were largely less stable in OA
chondrocytes but were also more highly expressed (Fig-
ure 3A). This indicates that altered transcription rates of
these genes in OA are higher than steady-state levels
alone would suggest. In addition, through this altered
posttranscriptional regulation, OA may still substantially
affect the regulatory dynamics controlling the expression
of these genes, altering the speed of their response to
further transcriptional stimulus (3). Further experiments
examining the longitudinal expression kinetics of these
identified genes in chondrocytes are clearly needed.
Our candidate gene confirmatory analysis also
demonstrated differential regulation in a variety of
genes, including RELA, a key transcription factor com-
ponent of the NF-B pathway, the transcription factor
SASH1, which we have previously shown is controlled
by hyperosmotic stimulation of chondrocytes (19), and
HS3ST3A1, which encodes a heparan sulfate sulfotrans-
ferase enzyme. We were interested to find that the
HAS2 mRNA was identified as being posttranscription-
ally regulated in OA. It encodes the enzyme hyaluronic
acid synthase 2, which performs a critical role in car-
tilage matrix assembly (48). It has been shown that
HAS2 mRNA can be regulated posttranscriptionally
in fibroblasts following glucocorticoid treatment (49)
and in osteosarcoma cells by the natural antisense
RNA HAS2-AS1 (50). We were also particularly inter-
ested to find that the ADAMTS1, ADAMTS5, and
ADAMTS9 mRNAs, which encode 3 aggrecanase en-
zymes (36,51,52), were turned over differently in OA
chondrocytes. Aggrecanases are responsible for the
breakdown of the proteoglycan aggrecan in the cartilage
ECM, which is crucial to healthy turnover of cartilage
matrix but can contribute to the development of OA.
ADAMTS5 has been identified as being critical to OA
progression in mice (35), and posttranscriptional regu-
lation of ADAMTS5 has already been implicated in the
development of OA through the action of miR-140 (53).
To our knowledge, this is the first observation of a
change in aggrecanase mRNA decay kinetics in OA
samples.
This is the first time that mRNA decay has been
investigated across the transcriptome in chondrocytes.
There are limitations in our current study that should be
identified. We have been using cells that are isolated
from tissue to ensure that the transcriptional inhibitor
actinomycin D would have uniform, rapid access to
them. Therefore, the cells will no longer experience
environmental cues from the cartilage ECM. This may
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mean that a process of homogenization, due to the
culture process, may mask subtler differences in cells
originating from different tissues. We are currently
developing ways of conducting these experiments in
explant culture to avoid these issues. A further limitation
is that the human chondrocyte experiments use normal
tissue samples, which were obtained from donors who
were considerably younger than the donors with OA. As
a consequence, the differences that we have seen be-
tween cells from these samples could be described as
being affected by aging and/or pathology. Therefore, to
determine the influence of age on mRNA decay in
chondrocytes, we analyzed young and old equine chon-
drocytes, and we found in a set of a candidate genes that
aging does not influence mRNA turnover. This supports
the notion that pathology is the driver of altered mRNA
decay in our human study, although a future study
examining aging in human tissue is warranted to confirm
this.
In conclusion, using an in vitro human chondro-
cyte culture system, we have been able to shed light on
the posttranscriptional regulatory landscape that exists
within chondrocytes. This has allowed us to identify
common patterns of mRNA turnover as well as specific
differences that occur due to pathology. As our aware-
ness of these processes develops, it should lead to
improvements in our understanding of gene and protein
regulation within cartilage during health and disease.
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